Clinical Trials Sponsored by Gruppo Italiano Studio Linfomi

Total 55 results

Gruppo Italiano Studio Linfomi

Completed

A Randomized Study With Oral Melphalan + Prednisone (MP) Versus Melphalan, + Prednisone + Thalidomide (MPT) for Newly Diagnosesd Elderly Patients With Multiple Myeloma

Multiple Myeloma

Italy
Gruppo Italiano Studio Linfomi

Completed

Study With Palonosetron Alone in Preventing Chemotherapy-induced Nausea and Vomiting in Untreated Patients With Aggressive Non Hodgkin's Lymphomas Who Underwent Moderately Emetogenic Chemotherapy (NHLPal)

Non Hodgkin's Lymphoma | Chemotherapy-Induced Nausea and Vomiting

Italy
Gruppo Italiano Studio Linfomi

Completed

Safety and Efficacy of Fludarabine and Cyclophosphamide + Rituximab

Follicular Lymphoma

Italy
Gruppo Italiano Studio Linfomi

Completed

Efficacy and Safety Study of Bendamustine With or Without Rituximab in Chronic Lymphoproliferative Disorders

Chronic Lymphocytic Leukaemia

Italy
Gruppo Italiano Studio Linfomi

Unknown

Study of Bendamustine, Lenalidomide and Low-dose Dexamethasone, for the Treatment of Patients With Relapsed Myeloma

Multiple Myeloma

Italy
Gruppo Italiano Studio Linfomi

Completed

Bendamustine and Rituximab As Salvage Therapy In Patients With Chronic Lymphoproliferative Disorders

Relapsed or Refractory Chronic Lymphoproliferative Disorders

Italy
Gruppo Italiano Studio Linfomi

Completed

HDS Plus PBPC Transplant Vs 4 More Courses of FrontLine Therapy in Pts With Aggressive NHL in PR After Induction Therapy

High-Grade Lymphomas

Italy
Gruppo Italiano Studio Linfomi

Completed

Treatment of Advanced Hodgkin's Disease (Stages IIB-III-IV) (HD2000)

Advanced Hodgkin Disease

Italy
Gruppo Italiano Studio Linfomi

Completed

VELCADE® Plus Rituximab in Non Hodgkin's Follicular Lymphoma

Non Hodgkin's Follicular Lymphoma

Italy
Gruppo Italiano Studio Linfomi

Unknown

Lenalidomide Plus Rituximab (R) in Non Follicular NHL

Indolent Non Hodgkin Lymphoma

Italy
Gruppo Italiano Studio Linfomi

Unknown

Prospective Collection of Biological Data of Prognostic Relevance in Patients With B-Cell Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia Stage A(0) | Chronic Lymphocytic Leukemia Stage A(I) | Chronic Lymphocytic Leukemia Stage A(II)

Italy
Gruppo Italiano Studio Linfomi

Unknown

Gonadal Toxicity in Women With Hodgkin Lymphoma (FertHD)

Hodgkin Lymphoma

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto
Fondazione Italiana Linfomi

Recruiting

Incidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis With Tixagevimab and Cilgavimab in Italy.

COVID-19 | Chronic Lymphocytic Leukemia | Indolent B-Cell Non-Hodgkin Lymphoma

Italy
Gruppo Italiano Terapie Innovative nei Linfomi

Completed

Comparison of HD Chemotherapy Followed by Auto-transplant and R-CHOP in High Risk Patients With DLBCL.

Diffuse Large B-Cell Lymphoma

Italy
Gruppo Italiano Multiregionale per lo studio dei...

Completed

Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell Lymphoma (DLBCL)

Diffuse Large B-Cell Lymphoma | POOR PROGNOSIS

Italy
Gruppo Italiano Studio Early Arthritis

Recruiting

Italian Registry of Arthritis on Biologic Therapy (GISEA)

Rheumatoid Arthritis

Italy
Azienda Ospedaliera San Giovanni Battista
Hoffmann-La Roche; University of Turin, Italy; Gruppo Italiano Trapianto di Midollo... and other collaborators

Unknown

Comparison of High-Dose Chemotherapy + Rituximab and CHOP + Rituximab in High-Risk Follicular Lymphoma

Follicular Lymphoma

Italy
Gruppo Italiano per lo Studio del Mieloma Multiplo

Completed

Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone in Elderly Myeloma Patients

Multiple Myeloma

Italy
Gruppo Italiano per lo Studio della Diverticolite...

Completed

Italian Study Group on Complicated Diverticulosis (GISDIC)

Diverticulitis

Italy
Gruppo Italiano Multidisciplinare per lo Studio...

Completed

Stop Vasodepressor Drugs in Reflex Syncope (STOP-VD)

Hypotensive Syncope

Italy
Gruppo Italiano Multidisciplinare per lo Studio...

Completed

Guideline-based Pacing Therapy for Reflex Syncope (SUP2)

Syncope

Italy
Gruppo Italiano per lo studio dei Carcinomi dell...

Unknown

Folfiri/aflIbercept in Metastatic coloreCTal Cancer patIents With RAS Validated Wild typE Status (DISTINCTIVE)

Advanced Colorectal Cancer

Italy
Gruppo Italiano per lo studio dei Carcinomi dell...

Completed

Trial Comparing Two Two Sequences of Therapy in Colorectal Metastatic Patients (COMETS)

Metastatic Colorectal Cancer

Italy
Gruppo Italiano Multiregionale per lo studio dei...
University of Turin, Italy; Fondazione Italiana Linfomi ONLUS; Centro di Riferimento...

Completed

Non-randomized Safety Study With Bortezomib/Rituximab in Relapsed/Refractory Indolent Lymphoma (LYM-2023)

Lymphoma | Non-Hodgkin Lymphoma

Italy
Associazione Italiana per lo Studio del Pancreas
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente; High Research...

Recruiting

Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL) (CASSANDRA)

Pancreas Ductal Adenocarcinoma

Italy
Gruppo Italiano per lo studio dei Carcinomi dell...
Regione Lombardia

Terminated

Low-Tox Vs Eox In Patients With Locally Advanced Unresectable Or Metastatic Gastric Cancer

Metastatic Gastric Cancer | Locally Advanced Unresectable Gastric Cancer

Italy
German Low Grade Lymphoma Study Group
European Organisation for Research and Treatment of Cancer - EORTC; Lymphoma... and other collaborators

Unknown

Chemotherapy Followed by Radiation Therapy and Peripheral Stem Cell Transplant Compared With Chemotherapy Plus Interferon Alfa in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma

Lymphoma

Belgium, Italy
Istituti Tumori Giovanni Paolo II
Gruppo Oncologico Italiano di Ricerca Clinica; Gruppo Oncologico Italia Meridionale and other collaborators

Unknown

Gemcitabine or Gemcitabine and Cisplatin in the Treatment of Advanced Pancreatic Cancer (GIP-1)

Pancreatic Cancer

Italy
Gruppo Italiano Multiregionale per lo studio dei...
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Completed

Observational Study for the Cytofluorimetric Analysis of Cerebrospinal Fluid in Non-Hodgkin's Lymphoma Patients (CFM)

Lymphoblastic Lymphoma | Diffuse Large Cell Lymphoma | Burkitt's Lymphoma

Italy
Policlinico Casilino ASL RMB
Gruppo Italiano Multidisciplinare per lo Studio della Sincope

Recruiting

Italian Cardioneuroablation Study for Neurocardiogenic Syncope Patients (ItalianCNA)

Neurally Mediated Syncope

Italy
Gruppo Italiano Multiregionale per lo studio dei...
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Terminated

Zevalin Twice in Aggressive Non-Hodgkin Lymphoma

Diffuse Large B-Cell Lymphoma

Italy
Gruppo Italiano Studio Linfomi
Registro Tumori di Modena; Registro Tumori di Reggio Emilia; Registro Tumori... and other collaborators

Completed

The Use of FDG-PET in Patient With Hodgkin Lymphoma: a Population Based Study From Northern Italy

Histologically Confirmed Classical Hodgkin Lymphoma According to the Current World Health Organisation Classification

Italy
Gruppo Italiano Malattie EMatologiche dell'Adulto
Study Alliance Leukemia (SAL) Group

Completed

Phase III Trial in Acute Promyelocytic Leukemia Patients (APL0406)

Leukemia

Germany, Italy, Austria
Ospedale Santa Croce-Carle Cuneo
Consorzio Mario Negri Sud; GITIL (GRUPPO ITALIANO TERAPIE INNOVATIVE NEI LINFOMI)

Unknown

Positron Emission Tomography (PET)-Adapted Chemotherapy In Advanced Hodgkin Lymphoma (HL) (HD0607)

HODGKIN LYMPHOMA

Israel, Italy
Gruppo Italiano per lo studio dei Carcinomi dell...
Azienda Ospedaliero, Universitaria Ospedali Riuniti

Completed

First-line Irinotecan, Lederfolin and 5FU (FOLFIRI) and Bevacizumab in Patients With Advanced Colorectal Cancer (CENTRAL)

Colorectal Cancer Stage II

Italy
Ospedale Policlinico San Martino
Bayer; Associazione Italiana per la Ricerca sul Cancro; Gruppo Italiano per lo...

Recruiting

Adjuvant Durvalumab Plus Regorafenib vs Untreated Control in Stage IV Colorectal Cancer Patients With no Evidence of Disease (NED): VIVA Trial (VIVA)

Colorectal Cancer Stage IV | No Evidence of Disease State

Italy
National Cancer Institute, Naples
Gruppo Oncologico Italia Meridionale; Gruppo Italiano per lo studio dei Carcinomi... and other collaborators

Terminated

CAPPA-2: Cisplatin Added to Gemcitabine in Poor Performance Advanced NSCLC Patients (CAPPA-2)

Non-Small Cell Lung Cancer

Italy
Grupo Oncológico para el Tratamiento y el Estudio...

Unknown

Trial of Rituximab, Bendamustine (RB) for Patients With Follicular Lymphoma Refractory or Relapsed After Treatment With R-chemotherapy in First Line

Follicular Non-Hodgking´s Lymphoma Refractory or Relapsed After Treatment With R-chemotherapy in First Line.

Spain
Gruppo Italiano per lo studio dei Carcinomi dell...
Mario Negri Institute for Pharmacological Research

Unknown

Metastatic Advanced Pancreas Sorafenib (MAPS)

Locally Advanced Pancreatic Cancer

Italy
Gruppo Italiano per lo studio dei Carcinomi dell...
Mario Negri Institute for Pharmacological Research

Completed

Gemcitabine/Cisplatin +/-Cetuximab in Patients With Locally Advanced or Metastatic EGFR-Positive Pancreatic Cancer (SPaCe-01)

Pancreatic Cancer

Italy
Grupo Oncológico para el Tratamiento y el Estudio...

Unknown

Consolidation Treatment With Y90-Ibritumomab Tiuxetan After R-CHOP Induction in High Risk Patients According to Follicular Lymphoma International Prognostic Index (FLIPI) With Follicular Lymphoma (GOTEL-FL1LC)

Follicular Lymphoma

Spain
Gruppo Italiano per lo studio dei Carcinomi dell...
Mario Negri Institute for Pharmacological Research

Completed

FOLFOX-4 3months Versus 6 Months and Bevacizumab as Adjuvant Therapy for Patients With Stage II/III Colon Cancer (TOSCA)

Colon Cancer

Italy
Centro Prevenzione Malattie Cardiovascolari N....
Gruppo Italiano Multidisciplinare per lo Studio della Sincope

Completed

Theophylline for Low Adenosine Syncope (THEO-USA)

Syncope

Italy
Mario Negri Institute for Pharmacological Research
Aventis Pharmaceuticals; Istituto Scientifico Romagnolo per lo Studio e la... and other collaborators

Completed

Intergroup Trial of Adjuvant Chemotherapy in Adenocarcinoma of the Stomach (ITACA-S)

Adenocarcinoma of the Gastroesophageal Junction | Adenocarcinoma of the Stomach

Italy
Gruppo Italiano per lo studio dei Carcinomi dell...
Hospira, now a wholly owned subsidiary of Pfizer

Completed

Second Line Chemotherapy for Advanced Pancreatic Cancer (SLAP)

Pancreatic Adenocarcinoma

Italy
Gruppo Italiano per lo studio dei Carcinomi dell...
Unità Sperimentazioni cliniche; Istituto Nazionale Tumori di Napoli

Completed

Abraxane and Gemcitabine Versus Gemcitabine Alone in Locally Advanced Unresectable Pancreatic Cancer. (GAP)

Pancreatic Cancer Stage II

Italy
European Organisation for Research and Treatment...
Fondazione Italiana Linfomi ONLUS; Lymphoma Study Association

Unknown

Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma (H10)

Lymphoma

Netherlands
Associazione Angela Serra per la ricerca sul cancro
Fondazione Italiana Linfomi ONLUS; INTERNATIONAL T-CELL NON-HODGKIN'S LYMPHOMA...

Completed

T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma

Lymphoma, T-Cell, Peripheral

United States, Korea, Republic of, Spain, Italy, United Kingdom, China, Switzerland, Israel, France, Argentina, Brazil, Chile, Slovakia, Uruguay
European Organisation for Research and Treatment...
Federation Francophone de Cancerologie Digestive; Arbeitsgemeinschaft fur Internistische... and other collaborators

Completed

Celecoxib Combined With Fluorouracil and Leucovorin in Treating Patients With Resected Stage III Adenocarcinoma (Cancer) of the Colon

Colorectal Cancer

Netherlands, Belgium, Austria
German CLL Study Group
Cancer Trials Ireland; Stichting Hemato-Oncologie voor Volwassenen Nederland... and other collaborators

Active, not recruiting

Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL) (CLL17)

Chronic Lymphoid Leukemia

Spain, Ireland, Austria, Denmark, Israel, Norway, Germany, Switzerland, Italy, Belgium, Finland, Sweden, Netherlands

Clinical Trials Sponsored by Gruppo Italiano Studio Linfomi

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations